Gupta Ayurvedic Pharmacy, Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 19-12-2024
- Paid Up Capital ₹ 0.49 M
as on 19-12-2024
- Company Age 38 Year, 5 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.92 M
as on 19-12-2024
- Revenue 37.88%
(FY 2022)
- Profit 40.07%
(FY 2022)
- Ebitda 38.10%
(FY 2022)
- Net Worth 56.47%
(FY 2022)
- Total Assets 10.48%
(FY 2022)
About Gupta Ayurvedic Pharmacy,
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.49 M.
The company currently has active open charges totaling ₹0.92 M.
Jaimangal Gupta, Suman Gupta, and Utkarsh Gupta serve as directors at the Company.
- CIN/LLPIN
U24232MP1986PTC003717
- Company No.
003717
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Dec 1986
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Jabalpur, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Gupta Ayurvedic Pharmacy Pvt Ltd., offer?
Gupta Ayurvedic Pharmacy Pvt Ltd., offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Ayurvedic Medicine, Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Ayurvedic Churna and Goli.
Who are the key members and board of directors at Gupta Ayurvedic Pharmacy,?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaimangal Gupta  | Director | 19-Dec-1986 | Current |
| Suman Gupta | Director | 01-Apr-1999 | Current |
| Utkarsh Gupta | Director | 01-Jun-2020 | Current |
Financial Performance of Gupta Ayurvedic Pharmacy,.
Gupta Ayurvedic Pharmacy Pvt Ltd.,, for the financial year ended 2022, experienced significant growth in revenue, with a 37.88% increase. The company also saw a substantial improvement in profitability, with a 40.07% increase in profit. The company's net worth Soared by an impressive increase of 56.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gupta Ayurvedic Pharmacy,?
In 2021, Gupta Ayurvedic Pharmacy, had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 21 Nov 2020 | ₹0.74 M | Open |
State Bank Of India Creation Date: 05 Jan 1994 | ₹0.18 M | Open |
How Many Employees Work at Gupta Ayurvedic Pharmacy,?
Unlock and access historical data on people associated with Gupta Ayurvedic Pharmacy,, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gupta Ayurvedic Pharmacy,, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gupta Ayurvedic Pharmacy,'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
